[1] |
SIEST G, PILLOT T, RÉGIS-BAILLY A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine[J]. Clin Chem, 1995, 41(8 Pt 1): 1068-1086.
|
[2] |
SKOOG L.Vascular aspects in Alzheimer's disease[J]. J Neural Transm Suppl, 2000,59: 37-43.
|
[3] |
CHAUDHARY R, LIKIDLILID A, PEERAPATDIT T, et al.Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease[J]. Cardiovasc Diabetol, 2012, 11:36.
|
[4] |
ZHANG M D, GU W, QIAO S B, et al.Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6 634 cases and 6 393 controls[J]. PLoS One, 2014, 9(4): e95463.
|
[5] |
GRAMMER T B, HOFFMANN M M, RENNER W, et al.Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: the Ludwigshafen risk and cardiovascular health study[J]. Atherosclerosis, 2011, 215(2):487-493.
|
[6] |
刘金凤,马洪胜,李峰.ApoE基因多态性与脂质代谢的相关性[J]. 中国老年学杂志,2012,32(9):1802-1804.
|
[7] |
ZENDE P D, BANKAR M P, KAMBLE P S, et al.Apolipoprotein e gene polymorphism and its effect on plasma lipids in arteriosclerosis[J]. J Clin Diagn Res, 2013, 7(10):2149-2152.
|
[8] |
刘文秀, 杨丽萍, 念馨, 等. 云南省纳西族2型糖尿病与载脂蛋白E基因多态性的相关性研究[J]. 中国糖尿病杂志, 2016, 24(5):402-406.
|
[9] |
魏二佳, 杨立业, 陈文延, 等. 潮汕人群自发性深部脑出血与载脂蛋白E基因多态性的关系[J]. 中国微侵袭神经外科杂志, 2017,22(1):27-31.
|
[10] |
刘国栋,王桦,汪琦,等. APOE基因多态性与血脂异常相关性分析[J]. 武汉大学学报(医学版),2017,38(2): 267-270.
|
[11] |
HU M,TOMLINSON B.Lipid-lowing pharmacogenomics in Chinese patients[J]. Expert Rev Cardiovasc Ther, 2013,11(8):985-997.
|
[12] |
HOPEWELL J C, PARISH S, OFFER A, et al.Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study[J]. Eur Heart J, 2013,34(13):982-992.
|
[13] |
MORENO J A, PÉREZ-JIMÉNEZ F, MARÍN C, et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E geneotype in healthy subjects[J]. J Nutr, 2004, 134(10):2517-2522.
|
[14] |
VAN DER BAAN F H, KNOL M J, MAITLAND-VAN DER ZEE A H, et al. Added value of oharmacogenetic testing in predicting statin response: results from the REGRESS trial[J]. Pharmacogenomics J, 2013, 13(4):318-324.
|
[15] |
ZHANG M D, GU W, QIAO S B, et al.Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6 634 cases and 6 393 controls[J]. PLoS One, 2014,9(4): e95463.
|